Document is current
Any future updates will be listed below
-
Authors
Han, Jian
Li, Xiu
Feng, Yanping
Guo, Yan
Wang, Binyou
Wang, Yilin
-
Funding
Funding for this research was provided by:
the Zigong Key Science and Technology Plan (2023-NKY-02-04)
the Zigong Medical Big Data and Artificial Intelligence Research Institute Collaborative Innovation Category (2023-YGY-3-01)
- License Information
-
More Information
Article History
Received: 10 July 2025
Accepted: 15 September 2025
First Online: 8 October 2025
Declarations
:
: This investigation strictly followed the Declaration of Helsinki, and received ethical approval from received ethical approval from the Zigong Mental Health Center in China (IRB number: 2023024). The IRB granted a waiver for ethical review of this secondary analysis based on three criteria: (1) original participant consent included authorization for future research using anonymized data; (2) no additional interventions were performed; and (3) all personally identifiable information was removed prior to secondary analysis.The research protocol incorporates a rigorous assessment process to determine participants’ competency to provide informed consent, focusing on their comprehension of the study’s objectives, procedures, potential hazards, and anticipated advantages. The consent documentation is crafted in language that is both clear and appropriate for individuals with schizophrenia. All participants have received comprehensive information regarding the study details and have independently provided their consent to participate.
: Not applicable.
: The authors declare no competing interests.
